Plakophilins in Gastric Cancer
Author Information
Author(s): Demirag Guzin G, Sullu Yurdanur, Gurgenyatagi Dilek, Okumus Nilgun O, Yucel Idris
Primary Institution: Ondokuz Mayis University, Faculty of Medicine
Hypothesis
The study explores the relationship between plakophilins (PKP1, PKP2, PKP3) and gastric cancer.
Conclusion
Decreased PKP2 and PKP3 may serve as early prognostic markers in gastric cancer.
Supporting Evidence
- PKP1 expression was unchanged in gastric cancer compared to normal tissues.
- PKP2 and PKP3 were significantly decreased in gastric cancer.
- Low PKP3 levels correlated with poor prognosis.
- Mean disease-free survival was 38 months and overall survival was 42 months.
Takeaway
This study looked at proteins called plakophilins in stomach cancer and found that lower levels of two of these proteins might mean the cancer is worse.
Methodology
Immunohistochemistry was used to compare PKP expression in 34 gastric adenocarcinomas and 20 normal gastric tissues.
Limitations
The study had a relatively small sample size and focused only on specific plakophilins.
Participant Demographics
Mean age was 60.3 years, with a female to male ratio of 8/26.
Statistical Information
P-Value
0.0000001 for PKP2, 0.0001 for PKP3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website